RMIT-led study highlights the urgent need for more drug testing facilities in Australia

An RNA interference therapy, targeting ANGPTL3 in the liver, drastically reduced fasting triglycerides in people with mixed hyperlipidemia, the ARCHES-2 trial showed. Used atop usual

Chatbots had mixed results when it came to providing direct-to-patient cancer-related advice and treatment strategies for a wide variety of cancers, according to two studies

Bris­tol My­ers Squibb is work­ing to­ward its ninth ap­proval for its Op­di­vo-Yer­voy com­bi­na­tion, this time in the first-line set­ting for ad­vanced liv­er can­cer. In topline